M.J.B. Aarts - Essers

Bloem, M., de Meza, M. M., Boreel, C. D. M., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Blokx, W. A. M., Boers-Sonderen, M. J., Bonenkamp, H. J., de Groot, J. W. B., Haanen, J. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., Rikhof, B., Simkens, L. H. J., Stevense-den Boer, M. A., van der Veldt, A. A. M., Suijkerbuijk, K. P. M., ... Wouters, M. W. J. M. (2026). Early Cessation of Adjuvant Anti-PD-1 Therapy in Stage III and IV Melanoma. International Journal of Cancer. Advance online publication. https://doi.org/10.1002/ijc.70738

Salhi, Y., Makrodimitris, S., van Wilpe, S., te Paske, I., de Weerd, V., Beaufort, C. M., Westgeest, H. M., Voortman, J., Aarts, M. J. B., Rijnders, M., van der Veldt, A. A. M., de Wit, R., Mehra, N., Wilting, S. M., & Robbrecht, D. G. J. (2026). Longitudinal genome-wide aneuploidy measurements in circulating cell-free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer. Molecular oncology, 20(9), 2175-2187. https://doi.org/10.1002/1878-0261.70272

Kelly, J. F., van der Meer, J. R. M., Lommen, K., Fazzi, G. E., Weinans, C. R. G. J., Li, X., Baldewijns, M. M. I. I., Ramaekers, B., Marcelissen, T., van Roermund, J. G., Kerkhofs, T., Aarts, M. J. B., de Meyer, T., Schouten, L. J., Samarska, I. V., & Smits, K. M. (2026). An independent evaluation of an architectural-based scoring system for renal cell carcinoma risk-stratification. Pathology - Research and Practice, 287, Article 156631. Advance online publication. https://doi.org/10.1016/j.prp.2026.156631

Boreel, C., de Ruijter, J., van Not, O., Bloem, M., Been, L., Aarts, M., van den Berkmortel, F., Blank, C., Boers-Sonderen, M., Bonenkamp, H., de Groot, J. W., Grünhagen, D., Haanen, J., Hilde Jalving, M., Piersma, D., Rikhof, B., Boer, M. S. D., van der Veldt, A., Simkens, L., ... Suijkerbuijk, K. (2026). Response and survival in unresectable in-transit metastatic melanoma according to treatment strategy. European Journal of Cancer, 244, Article 116889. https://doi.org/10.1016/j.ejca.2026.116889

Geidel, G., Fekade, N., Raabe, K., Smit, D. J., Adam, L., Heidrich, I., Rünger, A., Kött, J., Zell, T., Amaral, T., Ascierto, P. A., Corrie, P., Dummer, R., Eggermont, A., Guo, J., Hassel, J. C., Jalving, M., Johnson, D. B., Kandolf, L., ... Melanoma World Society Study Group (2026). Translating ctDNA into cutaneous melanoma care: An international expert survey. European Journal of Cancer, 239, Article 116676. https://doi.org/10.1016/j.ejca.2026.116676

Duijn, M., Yildirim, H., van den Hurk, C., Postema, A. W., Aarts, M. J. B., Aben, K., van Oijen, M. G. H., Bins, A. D., & Zondervan, P. J. (2026). Health-related Quality of Life in Localized and Metastatic Renal Cell Carcinoma: Insights from Patient-reported Outcome Measures. European Urology Open Science, 84, 50-57. https://doi.org/10.1016/j.euros.2025.12.017

Robbrecht, D. G. J., Salhi, Y., Martens, J. W. M., Aarts, M. J. B., Hamberg, P., van der Heijden, M. S., Voortman, J., Mehra, N., Westgeest, H. M., de Wit, R., Debets, R., Boormans, J. L., & Nakauma-González, J. A. (2026). Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort Analysis. European Urology Oncology, 9(1), 7-11. https://doi.org/10.1016/j.euo.2025.04.007

van den Hurk, K., Lommen, K., Coussement, L., van den Kerkhof, D., Beckers, M., Trooskens, G., Van Neste, L., Oosterhof, M., van Doorn, R., van den Oord, J. J., Kerkhofs, T., Aarts, M. J. B., Ramaekers, B., Joore, M., Winnepenninckx, V. J. L., Van Criekinge, W., Gallagher, W., De Meyer, T., Smits, K. M., & van Engeland, M. (2026). Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical Outcome. Journal of Investigative Dermatology, 146(2), 455-469.e5. https://doi.org/10.1016/j.jid.2025.07.010

Bloem, M., van den Eertwegh, A. J. M., Haanen, J. B. A. G., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Blokx, W. A. M., Boers-Sonderen, M. J., Boreel, C. D. M., De Groot, J. W. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., Rikhof, B., Simkens, L. H. J., Boer, A. M. S., Van Der Veldt, A. A. M., Wouters, M. W. J. M., & Suijkerbuijk, K. P. M. (2025). Induction therapy with BRAF/MEK inhibitors versus upfront ipilimumab/ nivolumab in poor prognostic advanced melanoma. European Journal of Cancer, 230, Article 116062. https://doi.org/10.1016/j.ejca.2025.116062

Kelly, J. F., Samarska, I. V., Ramaekers, B., Marcelissen, T., Van Roermund, J. G., Aarts, M. J. B., Kerkhofs, T., Hermans, T., Van Osch, F., De Meyer, T., Schouten, L. J., & Smits, K. M. (2025). Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkers. BMC Cancer, 25(1), Article 1672. https://doi.org/10.1186/s12885-025-14900-8